Sepsis is a life threatening condition which produces multi-organ dysfunction with profound circulatory and cellular derangements. Administration of E.Coli endotoxin (LPS) produces systemic inflammatory effects of sepsis including disruption of endothelial barrier, and if severe enough death. Whole body periodic acceleration (pGz) is the headward-footward motion of the body. pGz has been shown to induce pulsatile shear stress to the endothelium, thereby releasing vascular and cardio protective mediators. The purpose of this study was to determine whether or not pGz performed as a pre-treatment or post-treatment strategy improves survival in a lethal murine endotoxin model. This study was designed as a prospective randomized controlled study in mice. pGz was performed in mice as pre-treatment (pGz-LPS, 3 days prior to LPS), post-treatment (LPS-pGz, 30 min after LPS ) strategies or Control (LPS-CONT), in a lethal murine model of endotoxemia. Endotoxemia was induced with intraperitoneal injection of E.Coli (40mg/kg). In a separate group of mice, a nonspecific nitric oxide synthase inhibitor (L-NAME) was provided in their drinking water and pGz-LPS and LPS-pGz performed to determine the effect of nitric oxide (NO) inhibition on survival. In another subset of mice, micro vascular leakage was determined. Behavioral scoring around the clock was performed in all mice at 30 min intervals after LPS administration, until 48 hrs. survival or death. LPS induced 100% mortality in LPS-CONT animals by 30 hrs. In contrast, survival to 48 hrs. occurred in 60% of pGz-LPS and 80% of LPS-pGz. L-NAME abolished the survival effects of pGz. Microvascular leakage was markedly reduced in both pre and post pGz treated animals and was associated with increased TIE2 and p-
TIE2. In a murine model of lethal endotoxemia, pGz performed as a pre or post treatment strategy significantly improved survival, and markedly reduced microvascular leakage.
The effect was modulated, in part, by NO since a non-selective inhibitor of NO abolished the pGz survival effect. 1 2 Sepsis is a life-threatening condition of multi-organ dysfunction caused by a 3 dysregulated host response to infection. Septic shock is a subset of sepsis in which 4 profound circulatory cellular and metabolic abnormalities are associated with a greater 5 risk of mortality than sepsis alone (1) . Sepsis affects more than 1.5 million humans in the 6 USA with mortality rates of 15-30% (2) . The economic burden of sepsis is highly 7 significant. The Agency for Healthcare Research and Quality lists sepsis as the most 8 expensive condition treated in U.S. hospitals, costing nearly $24 billion in 2013, and 9 accounting for 6.2% of the aggregate costs for hospitalization in the USA (3) . Despite 10 hundreds of treatment trials dating to the 1960s, interventions to improve survival from 11 sepsis have not significantly lowered mortality. 12 Administration of lipopolysaccharide (LPS), the endotoxin derived from the 13 purified outer membrane of E. Coli, produces systemic inflammatory effects of sepsis in 14 mice. Exposure to LPS causes a dose-dependent activation of a widespread cascade of 15 inflammatory mediators that disrupt the endothelial barrier. This leads to intracellular 16 hyperpermeability, multiple organ dysfunction and if sufficiently severe, death (4) . Such 17 a situation calls for an effective, prompt, endothelial repair strategy that has not yet been 18 promulgated. Large quantities of nitric oxide that are released into the circulation through 19 the action of inducible nitric oxide synthase (iNOS) are an important component of this 20 inflammatory cascade in sepsis disruption to the endothelial barrier. In contrast, small 21 quantities of nitric oxide normally released from endothelial nitric oxide (eNOS) by 22 flowing blood are a crucial determinate of inter-endothelial junctions (5) . The potential 23 effectiveness of eNOS was reported by Yamashita et al almost 20 years ago in which 5 24 chronic overexpression of endothelial derived NO by transgenic mice resulted in 25 resistance to LPS-induced hypotension, lung injury and death (6) . 26 In this paper, we employed non-invasive, periodic acceleration (pGz), a means to 27 increase pulsatile shear stress to the endothelium a phenomenon that also takes place 28 during exercise to stimulate increase release of NO into the circulation as an alternative 29 to overexpression by transgenic nice. This was accomplished by rapidly and repetitively 30 moving a mouse in headward-footward direction to induce pulsatile shear stress to the 31 endothelium (7) (8) (9) . We and others reported that pulsatile shear increases expression of 32 both endothelial derived nitric oxide synthase (eNOS) and neuronal derived nitric oxide 33 synthase (nNOS) both which are produced in nanomolar concentrations, and are 34 important in modulating the anti-inflammatory response in sepsis (9) (10) (11) . We have 35 previously shown in animal models of whole body and focal ischemia reperfusion injury 36 of the heart, brain, and skeletal muscles, that pGz improves outcomes, (12) (13) (14) (15) (16) (17) (18) (19) . In part, 37 the effects of pGz are related to increased release of eNOS into the circulation as well as 38 prostaglandins, adrenomedullin, and signaling via Phosphoinositide 3-kinase protein 39 kinase B pathway (PI3K-AKT). pGz also reduces intracellular calcium overload at the 40 cellular level. (10, 11, (19) (20) (21) (22) . 41 We hypothesized that pGz performed as a pre-treatment or post-treatment strategy 42 in a lethal murine endotoxin model might confer improved survival. 43 44 2.0 MATERIALS AND METHODS 45 
INTRODUCTION

Animal Preparation & pGz
6 46 This study protocol was approved by the Institutional Animal Care and Use 47 Committee of Mount Sinai Medical Center and conforms to the Guide for the Care and 48 Use of Laboratory Animals published by the National Institutes of Health (NIH 49 Publication No. 85-23, revised 1996) Protocol No. 17-20-A-04. 50 The motion platform that imparts pGz has been previously described (18, 23) . The 51 platform moves the horizontally placed body in the z-plane. The frequency of periodic 52 acceleration has been previously determined in our laboratory for mice to be 480cpm. 53 The mice were acclimated to a mouse holder (Kent Scientific Design, Torrington, CT) for 54 2 days and thereafter the mice voluntarily walked into the mice holder. The mice holder 55 was placed on the pGz motion platform. pGz was carried out at a frequency of 480 56 cycles/minute and acceleration in the z-plane (Gz) of ± 3.9 m/sec 2 57 58 reduced microvascular leakage in all three vascular beds by 50% (Fig 2) . Expression of TIE2 was unchanged with LPS but both pre and post treatment with 145 pGz increased TIE2 by 150%. In contrast, p-TIE2 decreased after LPS by 50% and pre 146 and post treatment with pGz increased the latter to Sham levels (Fig 3) . 
Experimental Design
Table 1. Comparison of studies using non pharmacological pre or post treatment strategies in LPS induced sepsis in mice 174
Author
Year Survival was significantly decreased in L-NAME treated animals. The latter was 190 not surprising since other animal studies have also shown similar findings with non-191 selective NOS inhibition (30, 31) . Human studies performed with nonselective NOS 192 inhibition also support the latter (32, 33) . We have previously shown the time course of 193 eNOS upregulation and phosphorylation in both animal models and cells under pGz (11, 194 23 uncoupling are all important to take into consideration (6, (34) (35) (36) (37) (39) (40) (41) . eNOS has been 200 shown to modulate inflammatory response, and particularly that of NFĸβ and its crosstalk 201 with iNOS (42) . The effects of eNOS on other cytokines also remains to be determined.
It is important to acknowledge that a single plausible mechanism for our findings is not 203 possible, since pGz produces a multifaceted response of cytoprotective proteins, 204 including antioxidant defense (23, 43) . 205 Microvascular leakage has been described in various models of sepsis including 206 LPS and its etiology multifactorial, with endothelial dysfunction and disruption of tight 207 junctions via various mechanisms (44, 45) . We have shown that pGz both pre and post 208 treatment decreases microvascular leakage induced by LPS. The decrease in 209 microvascular leakage by pGz is also likely multifactorial. Microvascular leakage has 210 been shown by others to be decreased by eNOS. (46) . We also found that pGz produces 211 a significant increase in Tie2 and restoration of p-Tie2. Tie2 is a tyrosine receptor kinase 212 which has been shown to be important in maintenance of tight junctions and decreasing 213 vascular hyperpermeability and specifically during sepsis (47, 48) . Tie2 stimulation can 214 promote a broad range of microvascular anti-leakage including endothelial activation. 215 David et al showed a decrease in total Tie2 expression and phosphorylation in LPS 216 treated mice and a restoration and improved survival in mice pretreated with a known 217 Tie2 agonist (vaculotide) (49) . The latter has been shown to improve endothelial tight 218 junctions. Oxidative stress has been shown by others to be a hallmark of the 219 inflammatory response, and to play a role in microvascular leakage. We did not 220 specifically studied ROS production in this study but we have previously shown that pGz 221 in mice also increases antioxidant enzymes (SOD, Catalase) and total antioxidant 222 capacity (23) . . We utilized and orally administered dose of L-NAME, a nonspecific NO 261 inhibitor, since specific eNOS inhibitors in mice are lacking. It can be argued that the 262 exact dose of L-NAME each animal received may be slightly different, however the 263 effects of NO inhibition on survival from LPS were uniformly dismal. We also did not 264 compare pGz to any other intervention, since there are no other passive exercise 265 strategies suitable for comparison in mice with this level of LPS induced injury. 266 Notwithstanding the above limitations, we conclude that pGz is a simple method 267 which increases survival, and reduces microvascular leakage in a mouse model of LPS 268 induced endotoxin shock. pGz may serve as an adjunctive therapeutic strategy to current
